Page last updated: 2024-11-03

procarbazine and Duncan Disease

procarbazine has been researched along with Duncan Disease in 2 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Swinnen, LJ1
Mullen, GM1
Carr, TJ1
Costanzo, MR1
Fisher, RI1
Piusińska, A1
Sułek, K1
Ilnicki, S1
Betiuk, B1

Trials

1 trial available for procarbazine and Duncan Disease

ArticleYear
[Anxiety and depression during chemotherapy for lymphoproliferative diseases].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1996, Volume: 51, Issue:19-22

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Cyclophosphamide;

1996

Other Studies

1 other study available for procarbazine and Duncan Disease

ArticleYear
Aggressive treatment for postcardiac transplant lymphoproliferation.
    Blood, 1995, Nov-01, Volume: 86, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine

1995